Back
Arcutis Biotherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
ARQT
Arcutis Biotherapeutics
Last Price:
$14.31
Seasonality Move:
42.46%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.57 | Sell |
| 20-day SMA: | 13.43 | Buy |
| 50-day SMA: | 11.12 | Buy |
| 200-day SMA: | 9.93 | Buy |
| 8-day EMA: | 14.38 | Sell |
| 20-day EMA: | 13.42 | Buy |
| 50-day EMA: | 11.93 | Buy |
| 200-day EMA: | 10 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 60.67 | Buy |
| Chaikin Money Flow: | -1190193 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.51 - 14.33) | Buy |
| Bollinger Bands (100): | (8.74 - 12.2) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.30 while ARQT 8-day simple moving average is 14.57, which is a Sell signal.
-
The stock price of ARQT is 14.30 while Arcutis Biotherapeutics 20-day SMA is 13.43, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day simple moving average is 11.12 while ARQT share price is 14.30, making it a Buy technically.
-
ARQT stock price is 14.30 and Arcutis Biotherapeutics 200-day simple moving average is 9.93, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
55
Arcutis Biotherapeutics (ARQT)
is a Buy
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a BuyThe current Arcutis Biotherapeutics [ARQT] share price is $14.30. The Score for ARQT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.7B
Price in USD:
14.30
Share Volume:
1.6M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
15.79
52-Week Low:
3.07
Buy
55
Arcutis Biotherapeutics (ARQT)
is a Buy
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?The Arcutis Biotherapeutics stock price is 14.30 USD today.
-
Will ARQT stock go up or go down?Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcutis Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is not overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
-
Arcutis Biotherapeutics share price is 14.30 while ARQT 8-day exponential moving average is 14.38, which is a Sell signal.
-
The stock price of ARQT is 14.30 while Arcutis Biotherapeutics 20-day EMA is 13.42, which makes it a Buy.
-
Arcutis Biotherapeutics 50-day exponential moving average is 11.93 while ARQT share price is 14.30, making it a Buy technically.
-
ARQT stock price is 14.30 and Arcutis Biotherapeutics 200-day simple moving average is 10.00, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
-
ARQT Moving Average Covergence Divergence (MACD) indicator is 1.05, suggesting Arcutis Biotherapeutics is a Buy
-
Arcutis Biotherapeutics Relative Strength Index (RSI) is 60.67, which suggest Arcutis Biotherapeutics is overbought
-
The Bollinger Bands (25) for Arcutis Biotherapeutics is (11.51 - 14.33), which suggest Arcutis Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.74 - 12.2), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.